skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 141  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Exploring concurrent validity of the CLN2 Clinical Rating Scale: Comparison to PedsQL using cerliponase alfa clinical trial data
Material Type:
Article
Add to My Research

Exploring concurrent validity of the CLN2 Clinical Rating Scale: Comparison to PedsQL using cerliponase alfa clinical trial data

PloS one, 2024-05, Vol.19 (5), p.e0302382-e0302382 [Peer Reviewed Journal]

Copyright: © 2024 Specchio et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2024 Public Library of Science ;2024 Specchio et al 2024 Specchio et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0302382 ;PMID: 38776275

Full text available

2
ALX Oncology Holdings (ALXO: $14.21) accelerates decline; Chief Medical Officer Randolph Sophia sells; -81c [5.4%]
Material Type:
Newsletter Article
Add to My Research

ALX Oncology Holdings (ALXO: $14.21) accelerates decline; Chief Medical Officer Randolph Sophia sells; -81c [5.4%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 18, 2024

Digital Resources/Online E-Resources

3
Shattuck Labs (STTK: $7.84) in 5th consecutive fall; -$2.82 [26.5%] Vol Index 1.3 [1 is avg]
Material Type:
Newsletter Article
Add to My Research

Shattuck Labs (STTK: $7.84) in 5th consecutive fall; -$2.82 [26.5%] Vol Index 1.3 [1 is avg]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 17, 2024

Digital Resources/Online E-Resources

4
ALX Oncology Holdings (ALXO: $14.66) in 5th consecutive fall; Chief Medical Officer Randolph Sophia sells; -$2.29 [13.5%]
Material Type:
Newsletter Article
Add to My Research

ALX Oncology Holdings (ALXO: $14.66) in 5th consecutive fall; Chief Medical Officer Randolph Sophia sells; -$2.29 [13.5%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 17, 2024

Digital Resources/Online E-Resources

5
ALX Oncology Holdings (ALXO: $15.02) in 4th consecutive fall; -$1.93 [11.4%]
Material Type:
Newsletter Article
Add to My Research

ALX Oncology Holdings (ALXO: $15.02) in 4th consecutive fall; -$1.93 [11.4%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 16, 2024

Digital Resources/Online E-Resources

6
Kineta (KA: 43.0c) drops to one-month low; -9c [17.3%]
Material Type:
Newsletter Article
Add to My Research

Kineta (KA: 43.0c) drops to one-month low; -9c [17.3%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 16, 2024

Digital Resources/Online E-Resources

7
ALX Oncology Holdings (ALXO: $15.19) drops to 21-day low; -42c [2.7%]
Material Type:
Newsletter Article
Add to My Research

ALX Oncology Holdings (ALXO: $15.19) drops to 21-day low; -42c [2.7%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 15, 2024

Digital Resources/Online E-Resources

8
ALX Oncology Holdings top gainer in The Financial Advisory Group soars 45.4% in 46 days; -60c [3.7%]
Material Type:
Newsletter Article
Add to My Research

ALX Oncology Holdings top gainer in The Financial Advisory Group soars 45.4% in 46 days; -60c [3.7%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 14, 2024

Digital Resources/Online E-Resources

9
ALX Oncology Holdings top gainer in Bourgeon Capital Management soars 52.0% in 42 days; -74c [4.4%]
Material Type:
Newsletter Article
Add to My Research

ALX Oncology Holdings top gainer in Bourgeon Capital Management soars 52.0% in 42 days; -74c [4.4%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 11, 2024

Digital Resources/Online E-Resources

10
ALX Oncology Holdings (ALXO: $16.95) climbs 2.0% strengthening above moving average price; CEO Jaume Pons sells; +34c [2.0%]
Material Type:
Newsletter Article
Add to My Research

ALX Oncology Holdings (ALXO: $16.95) climbs 2.0% strengthening above moving average price; CEO Jaume Pons sells; +34c [2.0%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 10, 2024

Digital Resources/Online E-Resources

11
ALX Oncology Holdings (ALXO: $16.61) tumbles 5.4%; -95c [5.4%]
Material Type:
Newsletter Article
Add to My Research

ALX Oncology Holdings (ALXO: $16.61) tumbles 5.4%; -95c [5.4%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 9, 2024

Digital Resources/Online E-Resources

12
Cogent Biosciences (COGT: $7.78) climbs 2.8% on rising relative strength, hits 70-day high; +21c [2.8%]
Material Type:
Newsletter Article
Add to My Research

Cogent Biosciences (COGT: $7.78) climbs 2.8% on rising relative strength, hits 70-day high; +21c [2.8%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 8, 2024

Digital Resources/Online E-Resources

13
ALX Oncology Holdings top gainer in Bourgeon Capital Management soars 41.5% in 39 days, hits twenty-five-month high; +$1.78 [11.3%] Vol Index 1.6 [1 is avg]
Material Type:
Newsletter Article
Add to My Research

ALX Oncology Holdings top gainer in Bourgeon Capital Management soars 41.5% in 39 days, hits twenty-five-month high; +$1.78 [11.3%] Vol Index 1.6 [1 is avg]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 8, 2024

Digital Resources/Online E-Resources

14
Nuvectis Pharma (NVCT: $7.56) plunges 7.1% weakening below moving average price; -58c [7.1%] Vol Index 2.6 [1 is avg]
Material Type:
Newsletter Article
Add to My Research

Nuvectis Pharma (NVCT: $7.56) plunges 7.1% weakening below moving average price; -58c [7.1%] Vol Index 2.6 [1 is avg]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 7, 2024

Digital Resources/Online E-Resources

15
BioAtla (BCAB: $3.13) slides 3.7% on slipping relative strength; -12c [3.7%]
Material Type:
Newsletter Article
Add to My Research

BioAtla (BCAB: $3.13) slides 3.7% on slipping relative strength; -12c [3.7%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 7, 2024

Digital Resources/Online E-Resources

16
Two-bagger ALX Oncology Holdings (ALXO: $15.98) gains 4.0% on firm volume; +62c [4.0%]
Material Type:
Newsletter Article
Add to My Research

Two-bagger ALX Oncology Holdings (ALXO: $15.98) gains 4.0% on firm volume; +62c [4.0%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 7, 2024

Digital Resources/Online E-Resources

17
ALX Oncology Holdings (ALXO: $15.50) accelerates decline, down 8.5% in 2 days; -$1.44 [8.5%]
Material Type:
Newsletter Article
Add to My Research

ALX Oncology Holdings (ALXO: $15.50) accelerates decline, down 8.5% in 2 days; -$1.44 [8.5%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 4, 2024

Digital Resources/Online E-Resources

18
Greenwich LifeSciences (GLSI: $14.19) drops 1.8% on slipping relative strength; -26c [1.8%]
Material Type:
Newsletter Article
Add to My Research

Greenwich LifeSciences (GLSI: $14.19) drops 1.8% on slipping relative strength; -26c [1.8%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 18, 2024

Digital Resources/Online E-Resources

19
Anixa Biosciences (ANIX: $2.85) drops to six-month low; -6c [2.1%]
Material Type:
Newsletter Article
Add to My Research

Anixa Biosciences (ANIX: $2.85) drops to six-month low; -6c [2.1%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 18, 2024

Digital Resources/Online E-Resources

20
Kineta (KA: 45.0c) closes at 19% below VWAP; reports Loss of $10.2m; -3c [6.2%]
Material Type:
Newsletter Article
Add to My Research

Kineta (KA: 45.0c) closes at 19% below VWAP; reports Loss of $10.2m; -3c [6.2%]

News Bites US - NASDAQ, 2024

Copyright News Bites Pty Ltd May 18, 2024

Digital Resources/Online E-Resources

Results 1 - 20 of 141  for All Library Resources

Results 1 2 3 4 5 next page

Searching Remote Databases, Please Wait